financetom
Business
financetom
/
Business
/
Market Chatter: Microsoft-Backed OpenAI Eyes AI Device Startup Owned by Sam Altman, Jony Ive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Microsoft-Backed OpenAI Eyes AI Device Startup Owned by Sam Altman, Jony Ive
Apr 7, 2025 12:15 PM

02:49 PM EDT, 04/07/2025 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is interested in buying the startup of its CEO Sam Altman and Jony Ive, which is developing an artificial intelligence-powered household device, The Information reported, citing two sources close to the deal talks.

OpenAI reportedly offered at least $500 million for a complete buyout at one point. Current discussions also include partnership options, the news outlet quoted one of the sources as saying.

A buyout deal would include the AI design and the engineers working on it. Potential designs, which are still in early stages, could be a phone without a screen or other AI-enabled household devices, according to the news report.

OpenAI didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 360.13, Change: +0.29, Percent Change: +0.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Paycom Software Q2 Non-GAAP Earnings Steady, Revenue Rises; Share Buyback Plan Boosted
Paycom Software Q2 Non-GAAP Earnings Steady, Revenue Rises; Share Buyback Plan Boosted
Jul 31, 2024
05:57 PM EDT, 07/31/2024 (MT Newswires) -- Paycom Software ( PAYC ) reported Q2 non-GAAP earnings late Wednesday of $1.62 per diluted share, flat from a year earlier. Analysts polled by Capital IQ expected $1.60. Revenue for the quarter ended June 30 was $437.5 million, compared with $401.1 million a year earlier. Analysts surveyed by Capital IQ expected $436.4 million....
FMC Q2 Adjusted Earnings, Revenue Rise; Q3 Outlook Set; 2024 Guidance Revised -- Shares Jump After Hours
FMC Q2 Adjusted Earnings, Revenue Rise; Q3 Outlook Set; 2024 Guidance Revised -- Shares Jump After Hours
Jul 31, 2024
05:59 PM EDT, 07/31/2024 (MT Newswires) -- FMC (FMC) reported Q2 adjusted earnings late Wednesday of $0.63 per diluted share, up from $0.50 a year earlier. Analysts polled by Capital IQ expected $0.55. Revenue for the quarter ended June 30 was $1.04 billion, up from $1.01 billion a year earlier. Analysts surveyed by Capital IQ expected $1.03 billion. The company...
Exact Sciences Q2 Loss Narrows, Revenue Rises; Shares Jump After Hours; TwinStrand's Patent Estate Licensed
Exact Sciences Q2 Loss Narrows, Revenue Rises; Shares Jump After Hours; TwinStrand's Patent Estate Licensed
Jul 31, 2024
05:53 PM EDT, 07/31/2024 (MT Newswires) -- Exact Sciences ( EXAS ) reported a Q2 diluted loss Wednesday of $0.09 a share, narrowing from a loss of $0.45 a year earlier. Analysts polled by Capital IQ expected a loss of $0.33. Revenue in the quarter ended June 30 rose to $699.3 million from $622.1 million a year ago. Analysts polled...
Jazz Pharmaceuticals Q2 Non-GAAP Earnings, Revenue Rise, 2024 Outlook Updated
Jazz Pharmaceuticals Q2 Non-GAAP Earnings, Revenue Rise, 2024 Outlook Updated
Jul 31, 2024
05:58 PM EDT, 07/31/2024 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) late Wednesday reported Q2 non-GAAP net income of $5.30 per diluted share, up from $4.51 a year earlier. Analysts polled by Capital IQ expected $4.77. Revenue for the quarter ended June 30 was $1.02 billion, compared with $957.3 million a year earlier. Analysts expected $1 billion. For 2024,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved